Goldman Sachs’s Perspective Therapeutics CATX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $936K | Sell |
272,098
-30,721
| -10% | -$106K | ﹤0.01% | 3892 |
|
|
2025
Q1 | $645K | Sell |
302,819
-600,099
| -66% | -$1.28M | ﹤0.01% | 4109 |
|
|
2024
Q4 | $2.88M | Buy |
902,918
+454,235
| +101% | +$1.45M | ﹤0.01% | 3255 |
|
|
2024
Q3 | $5.99M | Buy |
+448,683
| New | +$5.99M | ﹤0.01% | 2629 |
|
|
2024
Q2 | – | Sell |
-1,996,511
| Closed | -$2.38M | – | 4750 |
|
|
2024
Q1 | $2.38M | Buy |
+1,996,511
| New | +$2.38M | ﹤0.01% | 3104 |
|
|
2023
Q4 | – | Sell |
-13,373
| Closed | -$3.66K | – | 4784 |
|
|
2023
Q3 | $3.66K | Buy |
+13,373
| New | +$3.66K | ﹤0.01% | 4661 |
|
|
2016
Q1 | – | Sell |
-11,210
| Closed | -$11K | – | 4493 |
|
|
2015
Q4 | $11K | Buy |
+11,210
| New | +$11K | ﹤0.01% | 4401 |
|
|
2015
Q1 | – | Sell |
-11,011
| Closed | -$16K | – | 4492 |
|
|
2014
Q4 | $16K | Sell |
11,011
-65,564
| -86% | -$95.3K | ﹤0.01% | 4496 |
|
|
2014
Q3 | $129K | Buy |
76,575
+40,639
| +113% | +$68.5K | ﹤0.01% | 4146 |
|
|
2014
Q2 | $112K | Buy |
+35,936
| New | +$112K | ﹤0.01% | 4158 |
|